Grifols Faces Scrutiny Over Plasma Contract Amid Reports of Deaths and Non-Compliance
Event summary
- Ontario and Manitoba Health Coalitions demand an end to Grifols’ for-profit blood plasma contract following reports of deaths and non-compliance at multiple centers.
- CBC reports two deaths in Winnipeg linked to plasma harvesting at Grifols centers, with additional allegations of kidney damage from equipment failure.
- Health Canada inspection reports show four Grifols centers found non-compliant in Calgary, St. John, Regina, and Saskatoon.
- Coalitions call for disclosure of contract terms between Canadian Blood Services (CBS) and Grifols, and an independent judicial inquest in Manitoba.
- CBS signed a 15-year contract with Grifols in 2022, allowing plasma harvesting up to 104 times per year—double the frequency allowed for CBS.
The big picture
The controversy surrounding Grifols’ plasma harvesting practices highlights the tension between for-profit healthcare services and public health safety. The case echoes broader debates over privatization in healthcare, particularly in light of past scandals like the tainted blood crisis in Canada. The strategic anomaly here is the exception in Ontario’s Voluntary Blood Donations Act, which allows CBS to pay donors but not contract for-profit entities—a loophole that Grifols has exploited. The scale of the issue is significant, with Grifols operating multiple centers and harvesting plasma at frequencies double those allowed for CBS.
What we're watching
- Regulatory Headwinds
- Whether Health Canada will impose stricter oversight or penalties on Grifols following the non-compliance reports and allegations of harm.
- Contract Risks
- How CBS will respond to calls to end its contract with Grifols and expand the voluntary public donation system.
- Public Trust
- The potential impact on Grifols’ reputation and operations if further adverse events or non-compliance issues are revealed.
Related topics